methionine has been researched along with Hepatitis B, Chronic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alagozlu, H; Coskun, M; Koksal, B; Ozdemir, O; Yilmaz, A | 1 |
| Wu, F; Wu, MJ; Zhu, B; Zhu, SM; Zhuge, XL | 1 |
| Hamada, K; Muramatsu, A; Nishioji, K; Oda, Y; Okuno, T; Shindo, M | 1 |
| Goto, T; Kato, N; Omata, M | 1 |
| Chan, AO; Lai, CL; Sum, SS; Wong, BC; Wong, DK; Yuan, HJ; Yuen, JC; Yuen, MF | 1 |
| Han, B; Wang, RS; Yang, ZJ; Zhang, H; Zhu, YF | 1 |
1 review(s) available for methionine and Hepatitis B, Chronic
| Article | Year |
|---|---|
[YMDD motif and its significance].
Topics: Amino Acid Motifs; Asparagine; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Methionine; Mutation; Reverse Transcriptase Inhibitors; Reverse Transcription; RNA-Directed DNA Polymerase; Tyrosine | 2004 |
1 trial(s) available for methionine and Hepatitis B, Chronic
| Article | Year |
|---|---|
Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection.
Topics: Adolescent; Adult; Amino Acid Motifs; Anti-HIV Agents; Aspartic Acid; DNA, Circular; DNA, Viral; Female; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Isoleucine; Lamivudine; Male; Methionine; Middle Aged; Mutation; Placebos; Reverse Transcriptase Inhibitors; Tyrosine; Valine; Viral Load | 2005 |
4 other study(ies) available for methionine and Hepatitis B, Chronic
| Article | Year |
|---|---|
Prevelance of common YMDD motif mutations in long term treated chronic HBV infections in a Turkish population.
Topics: Adenine; Adult; Aged; Amino Acid Motifs; Anti-HIV Agents; Antiviral Agents; Aspartic Acid; Case-Control Studies; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Female; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Methionine; Middle Aged; Mutation; Organophosphonates; Prognosis; Retrospective Studies; Turkey; Tyrosine | 2013 |
Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment.
Topics: Adult; Aged; Alanine Transaminase; Amino Acids; Antiviral Agents; Aspartic Acid; China; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Isoleucine; Lamivudine; Logistic Models; Male; Methionine; Middle Aged; Mutation; Retrospective Studies; Tyrosine; Valine | 2012 |
The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Aspartic Acid; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Liver Cirrhosis; Male; Methionine; Middle Aged; Mutation; Predictive Value of Tests; Retrospective Studies; Treatment Outcome; Tyrosine | 2004 |
Detection of YMDD mutants using universal template real-time PCR.
Topics: Antiviral Agents; Aspartic Acid; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Methionine; Mutation; Polymerase Chain Reaction; Sensitivity and Specificity; Sequence Analysis, DNA; Tyrosine | 2006 |